Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank86
3Y CAGR-2.7%
5Y CAGR+15.3%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-2.7%/yr
vs +25.0%/yr prior
5Y CAGR
+15.3%/yr
Recent deceleration
Acceleration
-27.7pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.08B | +11.3% |
| 2024 | $3.66B | -0.1% |
| 2023 | $3.67B | -17.1% |
| 2022 | $4.42B | -32.2% |
| 2021 | $6.53B | +225.9% |
| 2020 | $2.00B | +0.2% |
| 2019 | $2.00B | +10.4% |
| 2018 | $1.81B | +75.2% |
| 2017 | $1.03B | +6.2% |
| 2016 | $974.00M | - |